Table 1.

Comparison between GAP-predicted and observed mortality in our study cohort of IPF patients.

Disease Stage	3 Year Mortality Estimated by GAP	3 Year Observed Mortality
GAP-I	16%	21%
GAP-II	40%	46%
GAP-III	77%	70%